Please login to the form below

Not currently logged in
Email:
Password:

PPD expands global product department with new therapeutic area heads

Selects Daniel Burch, Puneet Mohan and Alan Solinger to fill the positions

PPD Daniel BurchContract research organisation (CRO) PPD has appointed Daniel Burch, Puneet Mohan and Alan Solinger to fill three new therapeutic area head positions.

The move expands the company's expertise in CNS, cardiovascular/metabolism and rheumatology/immunology and swells its global product department team.

Daniel Burch (pictured top right) joins PPD from CeNeRx BioPharma, where he was executive VP of R&D and chief medical officer. Prior to joining CeNeRx, Burch was at GlaxoSmithKline (GSK), where he most recently served as senior VP and head of GSK's neurosciences medicine development centre.

PPD Mohan Puneet

He has 20 years of experience in general management, global drug development, global medical affairs and business development.

Puneet Mohan (left) comes to PPD from Bristol-Myers Squibb, where he most recently served as executive director of global clinical development and global clinical leader for Eliquis (apixaban).

He held this role for eight of his 29-year medical career and prior to serving at BMS, Mohan was with Bayer.

PPD Alan SolingerAlan Solinger's (bottom right) medical career covers 30 years and he joins PPD from Californian biotech company Xoma, where he served as vice president of clinical immunology.

PPD's global product development team of six therapeutic area heads is managed by its global head of medical affairs Rob Dow.

"These experts have held senior leadership roles in top biopharma companies, and their expertise will bring added strategic value to our clients. I am pleased to welcome them to our team," he said.

Burch, Mohan and Solinger join PPD's existing therapeutic area heads of Carol Olson (infectious diseases), Dirk Reitsma (oncology) and Peter Summerfield (respiratory).

22nd February 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics